Next Article in Journal
Quantification of Bone Fatty Acid Metabolism and Its Regulation by Adipocyte Lipoprotein Lipase
Next Article in Special Issue
The Effects of Artemisinin on the Cytolytic Activity of Natural Killer (NK) Cells
Previous Article in Journal
Enhanced Osteogenic Differentiation in Zoledronate-Treated Osteoporotic Patients
Previous Article in Special Issue
Natural Killer Cells Response to IL-2 Stimulation Is Distinct between Ascites with the Presence or Absence of Malignant Cells in Ovarian Cancer Patients
Article

Amphotericin B, an Anti-Fungal Medication, Directly Increases the Cytotoxicity of NK Cells

by 1,2, 2,3, 3, 1,2 and 2,3,4,*
1
Department of Convergence Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul 05505, Korea
2
Asan Institute for Life Sciences, Asan Medical Center, University of Ulsan College of Medicine, Seoul 05505, Korea
3
Department of Biomedical Sciences, University of Ulsan College of Medicine, Asan Medical Center, Seoul 05505, Korea
4
Department of Microbiology, University of Ulsan College of Medicine, Asan Medical Center, Seoul 05505, Korea
*
Author to whom correspondence should be addressed.
Int. J. Mol. Sci. 2017, 18(6), 1262; https://doi.org/10.3390/ijms18061262
Received: 9 May 2017 / Revised: 2 June 2017 / Accepted: 9 June 2017 / Published: 13 June 2017
(This article belongs to the Special Issue Natural Killer (NK) Cells)
Immunomodulatory drugs (IMiDs) present one example of immunomodulatory agents that improve cancer immunotherapy. Based on the cytotoxic activity of natural killer (NK) cells against cancer cells, a high throughput screening method for the identification of novel immunomodulatory molecules with the potential to stimulate NK cell cytotoxicity against cancer cells was designed and tested using an approved drug library. Among the primary hit compounds, the anti-fungal drug amphotericin B (AMP-B) increased the cytotoxicity of NK cell line and human primary NK cells in a direct manner. The increase in NK cell activity was related to increased formation of NK-target cell conjugates and the subsequent granule polarization toward target cells. The results of the present study indicate that AMP-B could serve a dual function as an anti-fungal and immunomodulatory drug. View Full-Text
Keywords: immunomodulatory drugs; library screening; amphotericin B; natural killer cells; cytotoxicity immunomodulatory drugs; library screening; amphotericin B; natural killer cells; cytotoxicity
Show Figures

Graphical abstract

MDPI and ACS Style

Kim, N.; Choi, J.-W.; Park, H.-R.; Kim, I.; Kim, H.S. Amphotericin B, an Anti-Fungal Medication, Directly Increases the Cytotoxicity of NK Cells. Int. J. Mol. Sci. 2017, 18, 1262. https://doi.org/10.3390/ijms18061262

AMA Style

Kim N, Choi J-W, Park H-R, Kim I, Kim HS. Amphotericin B, an Anti-Fungal Medication, Directly Increases the Cytotoxicity of NK Cells. International Journal of Molecular Sciences. 2017; 18(6):1262. https://doi.org/10.3390/ijms18061262

Chicago/Turabian Style

Kim, Nayoung; Choi, Ji-Wan; Park, Hye-Ran; Kim, Inki; Kim, Hun S. 2017. "Amphotericin B, an Anti-Fungal Medication, Directly Increases the Cytotoxicity of NK Cells" Int. J. Mol. Sci. 18, no. 6: 1262. https://doi.org/10.3390/ijms18061262

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Search more from Scilit
 
Search
Back to TopTop